

[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
[ Tue, Mar 05th 2024
] - WOPRAI
Vamil Divan Maintained (ANIP) at Strong Buy with Increased Target to $77 on, Mar 5th, 2024
Vamil Divan of Guggenheim, Maintained "ANI Pharmaceuticals, Inc." (ANIP) at Strong Buy with Increased Target from $70 to $77 on, Mar 5th, 2024.
Vamil has made no other calls on ANIP in the last 4 months.
There are 2 other peers that have a rating on ANIP. Out of the 2 peers that are also analyzing ANIP, 0 agree with Vamil's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Vamil
- Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $83 on, Monday, March 4th, 2024
- Gregory Fraser of "Truist Securities" Maintained at Strong Buy with Increased Target to $80 on, Friday, March 1st, 2024
Contributing Sources